A federal judge has ordered that parts of the first AndroGel bellwether trial be retried, vacating a $150 million punitive damage award and ordering that the new trial focus solely on fraudulent misrepresentation claims.…
2017 was marked by a number of high-profile jury verdicts which often awarded plaintiffs tens of millions, or even hundreds of millions, of dollars for physical and financial injuries and illnesses caused by drugs, pollution and other products…
A federal judge has announced that a settlement has been reached resolving all Axiron testosterone lawsuits filed against Eli Lilly, cancelling two upcoming bellwether trials, which may be replaced with other cases.…
The federal judge overseeing all testosterone lawsuit has ordered parties to prepare 82 cases for trial over the next two years.…
Two Axiron testosterone lawsuits have been selected as bellwether trials, and are scheduled to go before juries in January and March of next year.…
The first Testim bellwether trial has ended in a verdict in the defense’s favor, as a Chicago jury found Auxillium not liable for a man’s heart attack after using the testosterone drug.…
Two additional testosterone trials are scheduled to begin in January as the pace of the bellwether program begins to ramp up over claims of heart attacks, deep vein thrombosis and pulmonary embolism injuries.…
A settlement status conference for AndroGel litigation is scheduled for November 2 following two massive verdicts against the manufacturer involve claims that the testosterone gel causes heart attacks and strokes.…
The first bellwether trial involving claims that the side effects of Testim, the testosterone gel, caused a man’s heart attack has survived a summary judgment effort by Auxilium and will proceed to trial on November 6, according to a court order.…
The first Testim testosterone gel lawsuit to go to trial will begin next month, with some stringent time limitations set by the federal judge overseeing the claims.…
